BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morimoto K, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Hamashige N, Abe M, Aoshima M, Ariyoshi K; Adult Pneumonia Study Group-Japan (APSG-J). The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One 2015;10:e0122247. [PMID: 25822890 DOI: 10.1371/journal.pone.0122247] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 12.6] [Reference Citation Analysis]
Number Citing Articles
1 Iwai-Saito K, Shobugawa Y, Kondo K. Social capital and pneumococcal vaccination (PPSV23) in community-dwelling older Japanese: a JAGES multilevel cross-sectional study. BMJ Open 2021;11:e043723. [PMID: 34140341 DOI: 10.1136/bmjopen-2020-043723] [Reference Citation Analysis]
2 Sato T, Ohkoshi Y, Wada T, Fukushima Y, Murabayashi H, Takakuwa Y, Nishiyama K, Shiraishi T, Nakajima C, Suzuki Y, Yokota SI. Complete Genome Sequence of Multidrug-Resistant Streptococcus pneumoniae Serotype 19F Isolated from an Invasive Infection in Sapporo, Japan. Genome Announc 2017;5:e01239-17. [PMID: 29097473 DOI: 10.1128/genomeA.01239-17] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Batais MA, Khan AR, Bin Abdulhak AA. The Use of Statins and Risk of Community-Acquired Pneumonia. Curr Infect Dis Rep 2017;19:26. [PMID: 28639080 DOI: 10.1007/s11908-017-0581-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Murakami Y, Kanazu S, Petigara T, Oba MS, Nishiwaki Y, Watanabe A. Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey. BMJ Open 2019;9:e030197. [PMID: 31315877 DOI: 10.1136/bmjopen-2019-030197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Takenouchi S, Sasahara T, Miyashita M, Kawa M, Umeda M, Kuwata M, Arahata T, Kizawa Y, Tamura K. Empowering Nurses Through Translating the End-of-Life Nursing Education Consortium: The End-of-Life Nursing Education Consortium–Japan Core Curriculum Project. J Hosp Palliat Nurs 2017;19:539-49. [DOI: 10.1097/njh.0000000000000385] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Nemoto M, Nakashima K, Noma S, Matsue Y, Yoshida K, Matsui H, Shiraishi A, Ishifuji T, Morimoto K, Ariyoshi K, Aoshima M. Prognostic value of chest computed tomography in community-acquired pneumonia patients. ERJ Open Res 2020;6:00079-2020. [PMID: 33263023 DOI: 10.1183/23120541.00079-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Takeda H, Sato C, Bin C, Nishidzuka M, Watanabe M, Yamamoto T, Suzuki H, Oishi K, Tsuchida F. Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children. J Glob Infect Dis 2019;11:30-5. [PMID: 30814833 DOI: 10.4103/jgid.jgid_167_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Katsurada N, Suzuki M, Aoshima M, Yaegashi M, Ishifuji T, Asoh N, Hamashige N, Abe M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group-Japan. The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study. BMC Infect Dis 2017;17:755. [PMID: 29212450 DOI: 10.1186/s12879-017-2858-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
9 Suzuki M, Katsurada N, Le MN, Kaneko N, Yaegashi M, Hosokawa N, Otsuka Y, Aoshima M, Yoshida LM, Morimoto K. Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan. Vaccine 2018;36:2960-7. [PMID: 29685596 DOI: 10.1016/j.vaccine.2018.04.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Kurbatova EA, Akhmatova NK, Zaytsev AE, Akhmatova EA, Egorova NB, Yastrebova NE, Sukhova EV, Yashunsky DV, Tsvetkov YE, Nifantiev NE. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to Streptococcus pneumoniae Type 3 Capsular Polysaccharide. Front Immunol 2020;11:578019. [PMID: 33343566 DOI: 10.3389/fimmu.2020.578019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Maki N, Takahashi H, Nakata T, Wakayama S, Hasegawa D, Sakamoto H, Fujita Y, Takata Y, Sukada T, Sato Y, Yanagi H. The Effect of Respiratory Rehabilitation for the Frail Elderly: a Pilot Study. Journal of General and Family Medicine 2016;17:289-98. [DOI: 10.14442/jgfm.17.4_289] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Nakato R, Manabe N, Hanayama K, Kusunoki H, Hata J, Haruma K. Diagnosis and treatments for oropharyngeal dysphagia: effects of capsaicin evaluated by newly developed ultrasonographic method. J Smooth Muscle Res 2020;56:46-57. [PMID: 32581185 DOI: 10.1540/jsmr.56.46] [Reference Citation Analysis]
13 Rastogi R, Yu PC, Deshpande A, Hashmi AZ, Herzig SJ, Rothberg MB. Treatment and outcomes among patients ≥85 years hospitalized with community-acquired pneumonia. J Investig Med 2021:jim-2021-002078. [PMID: 34702774 DOI: 10.1136/jim-2021-002078] [Reference Citation Analysis]
14 Nishida T, Yamabe K, Honda S. Dysphagia is associated with oral, physical, cognitive and psychological frailty in Japanese community-dwelling elderly persons. Gerodontology 2020;37:185-90. [PMID: 31874118 DOI: 10.1111/ger.12455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
15 Toda H, Satoh K, Komatsu M, Fukuda S, Nakamura T, Jikimoto T, Nishio H, Yamasaki K, Maede T, Orita T, Sueyoshi N, Kita M, Toyokawa M, Nishi I, Akagi M, Higuchi T, Kofuku T, Nakai I, Ono T, Shimakawa K, Hikita Y, Moro K, Kida K, Oohama M, Wada Y, Tobe T, Kamisako T, Tanaka Y. Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001-2015. J Infect Chemother 2018;24:171-6. [PMID: 29361416 DOI: 10.1016/j.jiac.2017.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
16 Jahanihashemi H, Babaie M, Bijani S, Bazzazan M, Bijani B. Poverty as an independent risk factor for in-hospital mortality in community-acquired pneumonia: A study in a developing country population. Int J Clin Pract 2018;72:e13085. [PMID: 29665161 DOI: 10.1111/ijcp.13085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kakiuchi S, Suzuki M, Dhoubhadel BG, Furumoto A, Ito H, Matsuki K, Tsuchihashi Y, Asoh N, Yasunami M, Ariyoshi K, Morimoto K. Accuracy of High-Throughput Nanofluidic PCR-Based Pneumococcal Serotyping and Quantification Assays Using Sputum Samples for Diagnosing Vaccine Serotype Pneumococcal Pneumonia: Analyses by Composite Diagnostic Standards and Bayesian Latent Class Models. J Clin Microbiol 2018;56:e01874-17. [PMID: 29444834 DOI: 10.1128/JCM.01874-17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Webber C, Patton M, Patterson S, Schmoele-Thoma B, Huijts SM, Bonten MJ; CAPiTA Study Group. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Vaccine 2017;35:1266-72. [PMID: 28173960 DOI: 10.1016/j.vaccine.2017.01.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
19 Noguchi S, Yatera K, Kato T, Chojin Y, Fujino Y, Akata K, Kawanami T, Sakamoto N, Mukae H. Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia. Clin Interv Aging 2017;12:2087-94. [PMID: 29263657 DOI: 10.2147/CIA.S150499] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
20 Igari H, Yamagishi K, Yamazaki S, Murata S, Yahaba M, Takayanagi S, Kawasaki Y, Taniguchi T. Epidemiology and treatment outcome of pneumonia: Analysis based on Japan national database. Journal of Infection and Chemotherapy 2020;26:58-62. [DOI: 10.1016/j.jiac.2019.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kusama T, Aida J, Yamamoto T, Kondo K, Osaka K. Infrequent Denture Cleaning Increased the Risk of Pneumonia among Community-dwelling Older Adults: A Population-based Cross-sectional Study. Sci Rep 2019;9:13734. [PMID: 31551442 DOI: 10.1038/s41598-019-50129-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
22 Miura Y, Nakagami G, Yabunaka K, Tohara H, Noguchi H, Mori T, Sanada H. A Randomized Controlled Trial to Investigate the Effectiveness of the Prevention of Aspiration Pneumonia Using Recommendations for Swallowing Care Guided by Ultrasound Examination. Healthcare (Basel) 2018;6:E15. [PMID: 29439537 DOI: 10.3390/healthcare6010015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Jiang Y, Yang X, Taniguchi K, Petigara T, Abe M. A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan. J Med Econ 2018;21:687-97. [PMID: 29723081 DOI: 10.1080/13696998.2018.1465272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Yasuda I, Suzuki M, Dhoubhadel BG, Terada M, Satoh A, Sando E, Hiraoka T, Kurihara M, Matsusaka N, Kawahara F, Ariyoshi K, Morimoto K. The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan. Vaccine 2020;38:3752-8. [PMID: 32265047 DOI: 10.1016/j.vaccine.2020.03.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Nagaoka K, Konno S, Murase K, Kikuchi T, Morinaga Y, Yanagihara K, Nakagawa I. Complete Genome Sequences of Streptococcus pneumoniae Strains HU-OH (Serotype 3, Sequence Type 183 [ST183]), NU83127 (Serotype 4, ST246), and ATCC 49619 (Serotype 19F, ST1203). Microbiol Resour Announc 2019;8:e01504-18. [PMID: 30834385 DOI: 10.1128/MRA.01504-18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Dhoubhadel BG, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Ishida M, Hamaguchi S, Aoshima M, Yasunami M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group-Japan (APSG-J). High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors. Thorax 2022:thoraxjnl-2021-217979. [PMID: 35474029 DOI: 10.1136/thoraxjnl-2021-217979] [Reference Citation Analysis]
27 Hasegawa S, Sada R, Yaegashi M, Morimoto K, Mori T; Adult Pneumonia Study Group-Japan. 1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia - a propensity score analysis of data from a Japanese multicenter registry. BMC Infect Dis 2019;19:1079. [PMID: 31878894 DOI: 10.1186/s12879-019-4552-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zhang M, Chen H, Wu F, Li Q, Lin Q, Cao H, Zhou X, Gu Z, Chen Q. Heightened Willingness toward Pneumococcal Vaccination in the Elderly Population in Shenzhen, China: A Cross-Sectional Study during the COVID-19 Pandemic. Vaccines (Basel) 2021;9:212. [PMID: 33802327 DOI: 10.3390/vaccines9030212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kurai D, Sasaki Y, Saraya T, Ishii H, Tsukagoshi H, Kozawa K, Ryo A, Ishioka T, Kuroda M, Oishi K, Takizawa H, Kimura H. Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia. Respir Investig 2016;54:255-63. [PMID: 27424825 DOI: 10.1016/j.resinv.2016.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
30 Wu CP, Chen YW, Wang MJ, Pinelis E. National Trends in Admission for Aspiration Pneumonia in the United States, 2002-2012. Ann Am Thorac Soc 2017;14:874-9. [PMID: 28272915 DOI: 10.1513/AnnalsATS.201611-867OC] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
31 Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, Hu B, Hu Z, Liao K, Sun H, Zhang R, Cao B, Zhuo C, Jia W, Mei Y, Chu Y, Xu X, Yang Q, Jin Y, Fu Q, Xu X, Li H, Wang L, Ni Y, Liang H, Wang H. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis 2017;17:804. [PMID: 29284419 DOI: 10.1186/s12879-017-2880-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
32 Kim B, Kim J, Jo YH, Lee JH, Hwang JE. The change in age distribution of CAP population in Korea with an estimation of clinical implications of increasing age threshold of current CURB65 and CRB65 scoring system. PLoS One 2019;14:e0219367. [PMID: 31415581 DOI: 10.1371/journal.pone.0219367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Suzuki R, Sakata N, Fushimi K. Association of body mass index with Clostridioides difficile infection among older patients with pneumonia in Japan. Geriatr Gerontol Int 2021. [PMID: 34852400 DOI: 10.1111/ggi.14316] [Reference Citation Analysis]
34 Tian Y, Liu H, Wu Y, Si Y, Li M, Wu Y, Wang X, Wang M, Chen L, Wei C, Wu T, Gao P, Hu Y. Ambient particulate matter pollution and adult hospital admissions for pneumonia in urban China: A national time series analysis for 2014 through 2017. PLoS Med 2019;16:e1003010. [PMID: 31891579 DOI: 10.1371/journal.pmed.1003010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
35 Patterson S, Webber C, Patton M, Drews W, Huijts SM, Bolkenbaas M, Gruber WC, Scott DA, Bonten MJ. A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults). Trials in Vaccinology 2016;5:92-6. [DOI: 10.1016/j.trivac.2016.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
36 Shinohara S, Sugaya M, Onitsuka T, Machida K, Matsuo M, Tanaka F. Impact of Postoperative Pneumonia Developing After Discharge on Long-Term Follow-up for Resected Lung Cancer. World J Surg 2018;42:3979-87. [PMID: 29946786 DOI: 10.1007/s00268-018-4727-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Çelikhisar H, Daşdemir Ilkhan G, Arabaci Ç. Prognostic factors in elderly patients admitted to the intensive care unit with community-acquired pneumonia. Aging Male 2020;23:1425-31. [PMID: 32543939 DOI: 10.1080/13685538.2020.1775192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Hu Y, Han Y, Yu C, Guo Y, Pei P, Yang L, Chen Y, Du H, Sun D, Pang Y, Niu W, Burgess S, Hacker A, Chen J, Chen Z, Lv J, Li L; China Kadoorie Biobank Collaborative Group. The hospitalization burden of all-cause pneumonia in China: A population-based study, 2009-2017. Lancet Reg Health West Pac 2022;22:100443. [PMID: 35400017 DOI: 10.1016/j.lanwpc.2022.100443] [Reference Citation Analysis]
39 Zhu-Ge D, Yang YP, Jiang ZJ. Knockdown CRNDE alleviates LPS-induced inflammation injury via FOXM1 in WI-38 cells. Biomed Pharmacother 2018;103:1678-87. [PMID: 29864958 DOI: 10.1016/j.biopha.2018.04.192] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
40 Grant LR, Slack MPE, Yan Q, Trzciński K, Barratt J, Sobczyk E, Appleby J, Cané A, Jodar L, Isturiz RE, Gessner BD. The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy. Expert Rev Vaccines 2021;20:691-705. [PMID: 34233558 DOI: 10.1080/14760584.2021.1921579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Dessie T, Jemal M, Maru M, Tiruneh M. Multiresistant Bacterial Pathogens Causing Bacterial Pneumonia and Analyses of Potential Risk Factors from Northeast Ethiopia. Int J Microbiol 2021;2021:6680343. [PMID: 33763137 DOI: 10.1155/2021/6680343] [Reference Citation Analysis]
42 Wang HT, Zhang H, Xue FZ, Zhao L, Cao WC. Associations of air pollutants with pneumonia hospital admissions in Qingdao, China: a prospective cohort study. Environ Sci Pollut Res Int 2022;29:27779-87. [PMID: 34981381 DOI: 10.1007/s11356-021-17892-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Glick HA, Miyazaki T, Hirano K, Gonzalez E, Jodar L, Gessner BD, Isturiz RE, Arguedas A, Kohno S, Suaya JA. One-Year Quality of Life Post-Pneumonia Diagnosis in Japanese Adults. Clin Infect Dis 2021;73:283-90. [PMID: 32447366 DOI: 10.1093/cid/ciaa595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Sakamoto A, Chanyasanha C, Sujirarat D, Matsumoto N, Nakazato M. Factors associated with pneumococcal vaccination in elderly people: a cross-sectional study among elderly club members in Miyakonojo City, Japan. BMC Public Health 2018;18:1172. [PMID: 30314498 DOI: 10.1186/s12889-018-6080-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
45 Shimbashi R, Suzuki M, Chang B, Watanabe H, Tanabe Y, Kuronuma K, Oshima K, Maruyama T, Takeda H, Kasahara K, Fujita J, Nishi J, Kubota T, Tanaka-Taya K, Matsui T, Sunagawa T, Oishi K; Adult IPD Study Group. Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017. Emerg Infect Dis 2020;26:2378-86. [PMID: 32946721 DOI: 10.3201/eid2610.191531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
46 Konomura K, Nagai H, Akazawa M. Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective. Pneumonia (Nathan) 2017;9:19. [PMID: 29226070 DOI: 10.1186/s41479-017-0042-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
47 Nishida T, Yamabe K, Honda S. The Influence of Dysphagia on Nutritional and Frailty Status among Community-Dwelling Older Adults. Nutrients 2021;13:512. [PMID: 33557341 DOI: 10.3390/nu13020512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Puerta-alcalde P, Cardozo-espinola C, Cilloniz C, Torres A, Garcia-vidal C. Has Mortality of Community-Acquired Pneumonia Really Reduced? Clinical Pulmonary Medicine 2017;24:258-62. [DOI: 10.1097/cpm.0000000000000233] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Ferreira-Coimbra J, Sarda C, Rello J. Burden of Community-Acquired Pneumonia and Unmet Clinical Needs. Adv Ther 2020;37:1302-18. [PMID: 32072494 DOI: 10.1007/s12325-020-01248-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
50 Kumar R, Dar L, Amarchand R, Saha S, Lafond KE, Purakayastha DR, Kumar R, Choudekar A, Gopal G, Dhakad S, Narayan VV, Wahi A, Chhokar R, Lindstrom S, Whitaker B, Choudhary A, Dey AB, Krishnan A. Incidence, risk factors, and viral etiology of community-acquired acute lower respiratory tract infection among older adults in rural north India. J Glob Health 2021;11:04027. [PMID: 33880179 DOI: 10.7189/jogh.11.04027] [Reference Citation Analysis]
51 Suzuki M, Dhoubhadel BG, Katoh S, Ariyoshi K, Morimoto K. 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia. The Lancet Infectious Diseases 2017;17:803-4. [DOI: 10.1016/s1473-3099(17)30411-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Cillóniz C, Rodríguez-hurtado D, Nicolini A, Torres A. Clinical Approach to Community-acquired Pneumonia. Journal of Thoracic Imaging 2018;33:273-81. [DOI: 10.1097/rti.0000000000000343] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
53 Chen L, Han X, Li Y, Zhang C, Xing X. Complications of Cardiovascular Events in Patients Hospitalized with Influenza-Related Pneumonia. Infect Drug Resist 2021;14:1363-73. [PMID: 33859482 DOI: 10.2147/IDR.S305509] [Reference Citation Analysis]
54 Wang M, Muraki I, Liu K, Shirai K, Tamakoshi A, Hu Y, Iso H. Diabetes and Mortality From Respiratory Diseases: The Japan Collaborative Cohort Study. J Epidemiol 2020;30:457-63. [PMID: 31839642 DOI: 10.2188/jea.JE20190091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Nguyen MTN, Saito N, Wagatsuma Y. The effect of comorbidities for the prognosis of community-acquired pneumonia: an epidemiologic study using a hospital surveillance in Japan. BMC Res Notes 2019;12:817. [PMID: 31856910 DOI: 10.1186/s13104-019-4848-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Miyashita N, Yamauchi Y. Bacterial Pneumonia in Elderly Japanese Populations. Jpn Clin Med 2018;9:1179670717751433. [PMID: 29434484 DOI: 10.1177/1179670717751433] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
57 Hida Y, Nishida T, Taniguchi C, Sakakibara H. Association between swallowing function and oral bacterial flora in independent community-dwelling elderly. Aging Clin Exp Res 2021;33:157-63. [PMID: 32152814 DOI: 10.1007/s40520-020-01521-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Tsuchiya M, Miyazaki H, Takata M, Shibuya R, Chang B, Ubukata K, Matsumoto T, Nakamura S. Comparative characteristics of the background and blood test findings in adults with pneumococcal pneumonia and invasive pneumococcal disease: A retrospective study. J Infect Chemother 2021:S1341-321X(21)00338-X. [PMID: 34924283 DOI: 10.1016/j.jiac.2021.12.002] [Reference Citation Analysis]
59 Kelley RC, Ferreira LF. Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology. Heart Fail Rev 2017;22:191-207. [PMID: 27000754 DOI: 10.1007/s10741-016-9549-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
60 Ikeda H. Plasma amino acid levels in individuals with bacterial pneumonia and healthy controls. Clin Nutr ESPEN 2021;44:204-10. [PMID: 34330467 DOI: 10.1016/j.clnesp.2021.06.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Trucchi C, Paganino C, Orsi A, Amicizia D, Tisa V, Piazza MF, Gallo D, Simonetti S, Buonopane B, Icardi G, Ansaldi F. Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old. BMC Health Serv Res 2019;19:585. [PMID: 31426795 DOI: 10.1186/s12913-019-4412-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
62 Sugimoto N, Yamagishi Y, Hirai J, Sakanashi D, Suematsu H, Nishiyama N, Koizumi Y, Mikamo H. Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review. BMC Res Notes 2017;10:21. [PMID: 28057059 DOI: 10.1186/s13104-016-2353-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
63 Takedani Y, Nakamura T, Fukiwake N, Imada T, Mashino J, Morimoto T. Clinical characteristics and factors related to antibiotic-associated diarrhea in elderly patients with pneumonia: a retrospective cohort study. BMC Geriatr 2021;21:317. [PMID: 34001039 DOI: 10.1186/s12877-021-02267-x] [Reference Citation Analysis]
64 Feldman C, Anderson R. Community-acquired pneumonia: still a major burden of disease. Current Opinion in Critical Care 2016;22:477-84. [DOI: 10.1097/mcc.0000000000000340] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
65 Hasegawa S, Shiraishi A, Yaegashi M, Hosokawa N, Morimoto K, Mori T. Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults. Journal of Comparative Effectiveness Research 2019;8:1275-84. [DOI: 10.2217/cer-2019-0041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
66 Peyrani P, Mandell L, Torres A, Tillotson GS. The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance. Expert Rev Respir Med 2019;13:139-52. [PMID: 30596308 DOI: 10.1080/17476348.2019.1562339] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
67 Krishnan A, Dar L, Amarchand R, Prabhakaran AO, Kumar R, Rajkumar P, Kanungo S, Bhardwaj SD, Choudekar A, Potdar V, Chakrabarti AK, Kumar CG, Parameswaran GG, Dhakad S, Manna B, Choudhary A, Lafond KE, Azziz-Baumgartner E, Saha S. Cohort profile: Indian Network of Population-Based Surveillance Platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE). BMJ Open 2021;11:e052473. [PMID: 34620665 DOI: 10.1136/bmjopen-2021-052473] [Reference Citation Analysis]
68 Igarashi A, Hirose E, Kobayashi Y, Yonemoto N, Lee B. Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan. Expert Rev Vaccines 2021;:1-13. [PMID: 34259118 DOI: 10.1080/14760584.2021.1952869] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Li X, Blais JE, Wong ICK, Tam AWY, Cowling BJ, Hung IFN, Chan EWY. Population-based estimates of the burden of pneumonia hospitalizations in Hong Kong, 2011-2015. Eur J Clin Microbiol Infect Dis 2019;38:553-61. [PMID: 30684165 DOI: 10.1007/s10096-018-03459-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Fukuda H, Onizuka H, Nishimura N, Kiyohara K. Risk factors for pneumococcal disease in persons with chronic medical conditions: Results from the LIFE Study. Int J Infect Dis 2022:S1201-9712(21)01263-7. [PMID: 34986403 DOI: 10.1016/j.ijid.2021.12.365] [Reference Citation Analysis]
71 Kawakami K, Kishino H, Kanazu S, Takahashi K, Iino T, Sawata M, Musey L. Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly. Hum Vaccin Immunother 2018;14:1931-8. [PMID: 29580133 DOI: 10.1080/21645515.2018.1456611] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
72 Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE). Vaccine 2019;37:2687-93. [PMID: 30975569 DOI: 10.1016/j.vaccine.2019.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
73 Muro S, Suzuki M, Nakamura S, Wang JR, Garry EM, Sakamoto W, de Souza S. Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis. Respir Res 2021;22:180. [PMID: 34140019 DOI: 10.1186/s12931-021-01776-y] [Reference Citation Analysis]
74 Sando E, Suzuki M, Ishida M, Yaegashi M, Aoshima M, Ariyoshi K, Morimoto K. Definitive and Indeterminate Pseudomonas aeruginosa Infection in Adults with Community-acquired Pneumonia: A Prospective Observational Study. Ann Am Thorac Soc 2021;18:1475-81. [PMID: 33565942 DOI: 10.1513/AnnalsATS.201906-459OC] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Heo JY, Song JY. Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines. Infect Chemother 2018;50:287-300. [PMID: 30600652 DOI: 10.3947/ic.2018.50.4.287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
76 Suzuki M, Dhoubhadel BG, Ishifuji T, Yasunami M, Yaegashi M, Asoh N, Ishida M, Hamaguchi S, Aoshima M, Ariyoshi K, Morimoto K. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. The Lancet Infectious Diseases 2017;17:313-21. [DOI: 10.1016/s1473-3099(17)30049-x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 41] [Article Influence: 19.2] [Reference Citation Analysis]
77 Maki N, Sakamoto H, Takata Y, Taniguchi K, Wijesinghe A, Okamura J, Kawamura T, Yanagihara T, Saeki Y, Kitazawa S, Kobayashi N, Kikuchi S, Goto Y, Ichimura H, Sato Y, Yanagi H. Effect of pulmonary training for community‐dwelling frail older adults with chronic stroke: A randomized controlled pilot trial. J Gen Fam Med. [DOI: 10.1002/jgf2.511] [Reference Citation Analysis]
78 Kanzaki R, Nagoya A, Kanou T, Ose N, Funaki S, Minami M, Okamoto Y, Tabuchi H, Hoshino T, Tajima T, Fujii M, Ohno Y, Shintani Y. Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2021;59:633-40. [PMID: 33849065 DOI: 10.1093/ejcts/ezaa333] [Reference Citation Analysis]
79 Ishizuka S, Yokoyama R, Sato K, Shiroma R, Nakahira A, Yamamoto H, Takano K, Kagesawa T, Miyasaka T, Kasamatsu J, Kanno E, Tanno H, Ishii K, Kawakami K. Effect of CARD9 Deficiency on Neutrophil-Mediated Host Defense against Pulmonary Infection with Streptococcus pneumoniae. Infect Immun 2020;89:e00305-20. [PMID: 33020213 DOI: 10.1128/IAI.00305-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Naito T, Suzuki M, Fujibayashi K, Kanazawa A, Takahashi H, Yokokawa H, Watanabe A. The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009-2018. J Infect Chemother 2020;26:407-10. [PMID: 31924523 DOI: 10.1016/j.jiac.2019.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Ishifuji T, Sando E, Kaneko N, Suzuki M, Kilgore PE, Ariyoshi K, Morimoto K, Hosokawa N, Yaegashi M, Aoshima M; Adult Pneumonia Study Group - Japan (APSG-J). Recurrent pneumonia among Japanese adults: disease burden and risk factors. BMC Pulm Med 2017;17:12. [PMID: 28077107 DOI: 10.1186/s12890-016-0359-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
82 Komiya K, Rubin BK, Kadota JI, Mukae H, Akaba T, Moro H, Aoki N, Tsukada H, Noguchi S, Shime N, Takahashi O, Kohno S. Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: A systematic review with meta-analysis. Sci Rep 2016;6:38097. [PMID: 27924871 DOI: 10.1038/srep38097] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
83 Johnson EK, Sylte D, Chaves SS, Li Y, Mahe C, Nair H, Paget J, van Pomeren T, Shi T, Viboud C, James SL. Hospital utilization rates for influenza and RSV: a novel approach and critical assessment. Popul Health Metr 2021;19:31. [PMID: 34126993 DOI: 10.1186/s12963-021-00252-5] [Reference Citation Analysis]
84 Yamazaki Y, Ikeda M, Imada T, Furuno K, Mizukami T, de Solom R, Shoji Y, Oe M, Aizawa M, Giardina PC, Schmoele-Thoma B, Scott DA. A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines. Vaccine 2021;39:6414-21. [PMID: 34563397 DOI: 10.1016/j.vaccine.2021.08.106] [Reference Citation Analysis]
85 Song JH, Huh K, Chung DR. Community-Acquired Pneumonia in the Asia-Pacific Region. Semin Respir Crit Care Med 2016;37:839-54. [PMID: 27960208 DOI: 10.1055/s-0036-1592075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
86 Javaudin F, Marjanovic N, de Carvalho H, Gaborit B, Le Bastard Q, Boucher E, Haroche D, Montassier E, Le Conte P. Contribution of lung ultrasound in diagnosis of community-acquired pneumonia in the emergency department: a prospective multicentre study. BMJ Open 2021;11:e046849. [PMID: 34561254 DOI: 10.1136/bmjopen-2020-046849] [Reference Citation Analysis]
87 Takeda S, Nagata N, Ueda Y, Ikeuchi N, Akagi T, Harada T, Miyazaki H, Ushijima S, Aoyama T, Yoshida Y, Yatsugi H, Wada K, Ishii H, Fujita M, Watanabe K. Study of factors related to recurrence within 30 days after pneumonia treatment for community-onset pneumonia. J Infect Chemother 2021;27:1683-8. [PMID: 34483030 DOI: 10.1016/j.jiac.2021.08.002] [Reference Citation Analysis]
88 Wolff E, Storsaeter J, Örtqvist Å, Naucler P, Larsson S, Lepp T, Roth A. Cost-effectiveness of pneumococcal vaccination for elderly in Sweden. Vaccine 2020;38:4988-95. [PMID: 32536548 DOI: 10.1016/j.vaccine.2020.05.072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
89 Hamaguchi S, Suzuki M, Sasaki K, Abe M, Wakabayashi T, Sando E, Yaegashi M, Morimoto S, Asoh N, Hamashige N, Aoshima M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group – Japan. Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study. BMC Pulm Med 2018;18:88. [PMID: 29792181 DOI: 10.1186/s12890-018-0648-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
90 Suzuki K, Kondo K, Washio M, Nakashima K, Kan S, Imai S, Yoshimura K, Ota C, Ohfuji S, Fukushima W, Hirota Y. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study. Hum Vaccin Immunother 2019;15:2171-7. [PMID: 30785356 DOI: 10.1080/21645515.2019.1584023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
91 Miyazaki H, Shibuya R, Chang B, Inukai T, Miyazaki Y, Ubukata K, Nakamura S, Matsumoto T. Genetic characteristics of piliated Streptococcus pneumoniae serotype 35B, increased after introduction of pneumococcal vaccines in Japan. J Infect Chemother 2020;26:1198-204. [PMID: 32682683 DOI: 10.1016/j.jiac.2020.06.016] [Reference Citation Analysis]
92 Nakamura A, Kawakami K, Wakana A, Folaranmi TA, Iino T. A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitude. Hum Vaccin Immunother 2020;16:2292-9. [PMID: 32045317 DOI: 10.1080/21645515.2020.1717184] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Iwai-Saito K, Shobugawa Y, Aida J, Kondo K. Frailty is associated with susceptibility and severity of pneumonia in older adults (A JAGES multilevel cross-sectional study). Sci Rep 2021;11:7966. [PMID: 33846416 DOI: 10.1038/s41598-021-86854-3] [Reference Citation Analysis]
94 Furman CD, Leinenbach A, Usher R, Elikkottil J, Arnold FW. Pneumonia in older adults. Curr Opin Infect Dis 2021;34:135-41. [PMID: 33470665 DOI: 10.1097/QCO.0000000000000718] [Reference Citation Analysis]
95 Partouche H, Lepoutre A, Vaure CBD, Poisson T, Toubiana L, Gilberg S. Incidence of all-cause adult community-acquired pneumonia in primary care settings in France. Médecine et Maladies Infectieuses 2018;48:389-95. [DOI: 10.1016/j.medmal.2018.02.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
96 Ishiwada N. Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan. J Infect Chemother 2021;27:7-18. [PMID: 33011068 DOI: 10.1016/j.jiac.2020.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Kobayashi K, Jo T, Mimura W, Suzukawa M, Ohshima N, Tanaka G, Akazawa M, Matsui H, Fushimi K, Yasunaga H, Nagase T, Nagai H. Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data. Hum Vaccin Immunother 2021;:1-9. [PMID: 33877954 DOI: 10.1080/21645515.2021.1875760] [Reference Citation Analysis]
98 Suzuki M, Katoh S, Miyahara R, Ariyoshi K, Morimoto K. Accuracy of composite diagnostic standards for pneumococcal pneumonia in vaccine trials. Epidemiol Infect 2018;146:712-5. [PMID: 29606164 DOI: 10.1017/S0950268818000651] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]